Fredun Pharmaceuticals Ltd — Updates, 10-07-2025: Company Update

Fredun Pharmaceuticals has announced receipt of a SEBI Adjudication Order related to alleged non-compliance in financial reporting and corporate governance between FY 2017-18 and FY 2021-22. Issues include not preparing financial statements as per Indian Accounting Standards, submitting audit reports without peer-reviewed auditors, incorrect certification on corporate governance applicability, failure to maintain audit committee quorum, and omission of compliance certificates with the Directors’ Report. No monetary penalty was imposed, and the order has no impact on the company’s financials or operations. This clarifies regulatory concerns without affecting business fundamentals.